AzTrials
AzTrials

Blood Oxygen Saturation LevelNCT01732029

Calibration and Evaluation of an Audio Pulse Oximeter Sensor (AudioOx) at Ascent and Descent From Simulated Altitude

A study testing Normobaric hypoxia chamber in people with Blood Oxygen Saturation Level and Heart Rate, run by University of British Columbia at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pulse oximetry is a standard non-invasive method of measuring blood oxygen saturation (SpO2). In developing countries, pulse oximeters are rare because of expense and electricity requirements. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Blood Oxygen Saturation Level, Heart Rate
What is being tested?
Normobaric hypoxia chamber
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
Jan 2013to Aug 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Non-smokers
  • UBC students age 18 and older or non-university students age 19 and older
  • No medical history of respiratory, cardiovascular and neurological problems (capable of undergoing controlled hypoxemia down to SpO2 of 70%).

Who cannot join

  • Medical history including respiratory, cardiovascular and neurological problems
  • Smokers or individuals exposed to high levels of carbon monoxide that result in elevated carboxyhemoglobin levels (interferes with oximetry readings)

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • BC Children's Hospital

    Vancouver, British Columbia, V6H 3V4

Other trials in Canada

About this study

Pulse oximetry is a standard non-invasive method of measuring blood oxygen saturation (SpO2). In developing countries, pulse oximeters are rare because of expense and electricity requirements. Our ECEM group has developed the Phone Oximeter, which uses a cell phone (which are widely available in developing countries) to compute and analyze information from a pulse oximeter sensor. To further reduce costs, we have developed an oximeter sensor (AudioOx) that plugs into the audio jack of a standard cell phone. This study aims to calibrate the AudioOx by exposing 30 healthy adult volunteers to various altitudes in UBC's hypoxia chamber.

Read the detailed description

Purpose:

We at the Electrical and Computer Engineering in Medicine Group (ECEM) at the University of British Columbia, Vancouver, Canada, plan to make pulse oximetry available to resource poor countries by designing a low-cost, battery-powered pulse oximeter device consisting of a low-cost pulse oximeter sensor connected to a cell phone. The use of cell phones as patient monitors is appealing as they are widely available in many developing countries. Utilizing battery power, cell phones do not rely on a continuous source of electricity. This is essential, as most low-resource settings lack adequate infrastructure and thus cannot provide the uninterrupted power supply required for conventional patient monitoring. Furthermore, a cell phone has the efficiency, integrated display, and processing power required to analyze and store the raw data derived from the pulse oximeter sensors. Data from the pulse oximeter can be transmitted to referral centers for diagnostic and advisory purposes where cellular and networking services permit.

Proprietary oximeter sensors and modules are expensive. To reduce cost, we are proposing to develop a simple audio pulse oximeter sensor (AudioOx) that that does not require a sensor module and interfaces via the audio jack of any standard cell phone. By utilizing the audio jack for transmission of data from the sensor to phone, we can ensure that cell phone types most common in various areas of the world are universally supported. Preliminary laboratory tests showed that oximetry data from the AudioOx has sufficient signal strength and resolution for extraction of heart rate and SpO2.

Hypothesis:

We hypothesize that this study will allow us to successfully calibrate the AudioOx.

Justification:

Development of pulse oximeters requires calibration and evaluation for accuracy. There is no acceptable surrogate calibration tool for pulse oximeters. To quote the current International Organization for Standardization (ISO) Pulse Oximetry standard document: "There is today no accepted method of verifying the correct calibration of a pulse oximeter probe/pulse oximeter monitor combination other than testing on human beings. This is due to the complexity of the optical intricacies of the interaction of light and human tissue upon which pulse oximetry depends".

A previous calibration study was performed on volunteers during a concurrent study in the UBC hypoxia chamber. The results demonstrated that the AudioOx can be calibrated to within the 4% accuracy required by ISO. The study setup, however, was suboptimal as the measured SpO2 data was predominantly hypoxic. Motion artifacts were also abundant, as the subjects had unrestricted movement.

Objectives:

Our main objective is to improve the calibration of the AudioOx by:

  • Asking subjects to remain relatively immobile during data measurement.
  • Exposing subjects to a very gradual change in oxygen concentration so that measurements are distributed over the entire clinical range of SpO2 (70% to 100%).
  • Using two (instead of one) clinically-approved pulse oximeters from different manufacturers as secondary reference standards.

Our secondary objective is to evaluate and compare the performance of the AudioOx during motion, low perfusion, and rapidly changing SpO2 by:

  • Asking the subjects to perform standardized hand and finger motions during data measurement.
  • Simulating low perfusion via two methods: by partially occluding the brachial artery using a blood pressure cuff and by having the patient raise their arm for two minutes and using light filters to reduce the red and infra-red signals detected by the pulse oximeter sensors.
  • Measuring SpO2 as the subject enters and exits the hypoxia chamber.

Research Method:

This will be a non-invasive concurrent observational study of healthy voluntary adult subjects in a normobaric (sea-level atmospheric pressure) hypoxia (low oxygen) chamber.

Study subjects will be put into a hypoxic state by exposing them to normobaric hypoxia by administrating an air mix containing a reduced O2 concentration. This is achieved in a hypoxia chamber where O2 concentration is gradually reduced to simulate high altitude (about 4500 m).

The goals of the current study are very similar to another study conducted in the hypoxia chamber (REB ID#H12-02362, The Camera Oximeter), the same methodology is applied. This will allow recruiting subjects for both studies and will reduce the total number of subjects necessary for achieving our goal.

Statistical Analysis:

Calibration of SpO2 Data from the initial set of subjects (at least 10) in the study will be used to calibrate the AudioOx oximetry data. Firstly, ratio R is calculated from the red and infra-red (IR) photo-absorbance signals, where

R = ( ACRED / DCRED ) / ( ACIR / DCIR )

ACRED and ACIR are pulsatile components of the red and infra-red light detected by the oximeter photosensor. DCRED and DCIR are constant components of the red and infra-red light detected by the oximeter photosensor.

R values are paired to the reference SpO2 values (average of the two readings from the two reference pulse oximeters) and plotted on a scatter plot. Depending on the shape of the plot, the R values are translated to SpO2 values using a linear equation, multiple linear equations, or polynomial equations.

Evaluation of Accuracy

Readings from the oximeter sensors are grouped into six ranges (70-75%, 76-80%, 81-85%, 86-90%, 91-95% and 96-100%). For each range of SpO2 and the overall range (70-100%) accuracy will be calculated as per ISO definitions:

Accuracy of the pulse oximeter shall be stated in terms of the root-mean-square (rms) difference between AudioOx values (SpO2i) and reference values (SRi), as given by:

Arms = √((∑i=1 to n(SpO2i- SRi)^2 )/n)

To express Accuracy relative to the "gold-standard" blood gas analysis, the error of the secondary standard pulse oximeter (errorref) will be included:

Accuracy = √(Arms^2 + error(ref)^2)

Motion \& low perfusion will be quantified by the proportion of time that the test measurements either gave no readings or were more than 4% different from the corresponding control measurements.

Being tested
Normobaric hypoxia chamber
Keywords
pulse oximeter, oxygen saturation, heart rate, calibration, accuracy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Normobaric hypoxia chamberOther

Study groups in NCT01732029
Study groupRoleWhat they receive
Normobaric hypoxia chamberOtherStudy subjects will be put into a hypoxic state by exposing them to normobaric hypoxia by administrating an air mix containing a reduced O2 concentration. This is achieved in a hypoxia chamber where O2 concentration is gradually reduced to simulate high altitude (about 4500 m).
Receives: Other: Normobaric hypoxia chamber

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygen saturation

    Accurately calibrated AudioOx for measuring oxygen saturation

    Measured: Across 3 hours

Secondary outcomes (1)
  1. Heart rate

    Accurately calibrated AudioOx for measuring heart rate

    Measured: Across 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2012 (estimated)
  2. Study startJan 2013
  3. Primary completionAug 2013
  4. Study completionAug 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01732029
Sponsor's protocol ID
H12-02365
Status last verified
Jun 2017
First submitted
16 Nov 2012
Last updated
26 Jun 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Normobaric hypoxia chamber in people with Blood Oxygen Saturation Level and Heart Rate, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygen saturation (time frame: Across 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in